Bg pattern

LATANOPROST YONSUNG 50 micrograms/ml eye drops in single dose containers

Prescription review online

Prescription review online

A doctor will review your case and decide whether a prescription is medically appropriate.

Talk to a doctor about this medicine

Talk to a doctor about this medicine

Discuss your symptoms and possible next steps in a quick online consultation.

This page is for general information. Consult a doctor for personal advice. Call emergency services if symptoms are severe.
About the medicine

How to use LATANOPROST YONSUNG 50 micrograms/ml eye drops in single dose containers

Translated with AI

This page provides general information and does not replace a doctor’s consultation. Always consult a doctor before taking any medication. Seek urgent medical care if symptoms are severe.

Show original

Introduction

Package Leaflet: Information for the Patient

Latanoprost Yonsung 50 micrograms/ml eye drops, solution in single-dose container

Read the entire package leaflet carefully before starting to use this medication, as it contains important information for you.

  • Keep this package leaflet, as you may need to read it again.
  • If you have any questions, consult your doctor or pharmacist.
  • This medication has been prescribed to you only, and you should not give it to others, even if they have the same symptoms as you, as it may harm them.
  • If you experience side effects, consult your doctor or pharmacist, even if they are not listed in this package leaflet. See section 4.

Contents of the Package Leaflet

  1. What Latanoprost Yonsung is and what it is used for
  2. What you need to know before starting to use Latanoprost Yonsung
  3. How to use Latanoprost Yonsung
  4. Possible side effects
  5. Storage of Latanoprost Yonsung
  6. Contents of the pack and further information

1. What Latanoprost Yonsung is and what it is used for

Latanoprost Yonsung belongs to a group of medications known as prostaglandin analogs. It works by increasing the natural outflow of fluid from the inside of the eye into the bloodstream.

Latanoprost Yonsung is used to treat diseases known as open-angle glaucoma and ocular hypertension. Both diseases are related to an increase in pressure inside the eye, which can affect vision.

Doctor consultation

Not sure if this medicine is right for you?

Discuss your symptoms and treatment with a doctor online.

2. What you need to know before starting to use Latanoprost Yonsung

Do not use Latanoprost Yonsung

If you are allergic (hypersensitive) to latanoprost or any of the other components of this medication (listed in section 6).

Warnings and precautions

Consult your doctor or pharmacist before starting to use latanoprost if you think any of the following situations apply to you:

  • If you have undergone or are going to undergo eye surgery (including cataract surgery).
  • If you have eye problems (such as eye pain, irritation, or inflammation, blurred vision).
  • If you have dry eyes.
  • If you have severe asthma or uncontrolled asthma.
  • If you use contact lenses. You can continue to use latanoprost, but you must follow the instructions included in section 3 for contact lens users.
  • If you have had or are having a viral eye infection caused by the herpes simplex virus (HSV).

Children

The use of this medication has not been studied in children (under 18 years of age).

Other medications and Latanoprost Yonsung

Latanoprost may interact with other medications. Inform your doctor or pharmacist if you are using, have recently used, or may need to use any other medication.

Pregnancy and breastfeeding

Do not use Latanoprost Yonsungif you are pregnant or breastfeeding, unless your doctor considers it necessary.

If you are pregnant or breastfeeding, think you may be pregnant, or plan to become pregnant, consult your doctor or pharmacist before using this medication.

Driving and using machines

When using latanoprost, blurred vision may occur for a short period. If this happens, do not driveor use tools or machines until your vision is clear again.

Latanoprost Yonsung contains phosphates

This medication contains 6.3 mg/ml of phosphates, which is equivalent to 0.24 mg/drop.

If you have severe damage to the clear layer on the front of the eye (the cornea), treatment with phosphates, in very rare cases, may cause cloudy patches on the cornea due to calcium deposits produced during treatment.

3. How to use Latanoprost Yonsung

  • Follow your doctor's instructions for using latanoprost exactly. If you are unsure, consult your doctor or pharmacist again.
  • The usual dose for adults (including elderly patients) is one drop in the affected eye(s) once a day. It is preferable to administer it at night.
  • Do not use latanoprost more than once a day, as the effectiveness of the treatment may decrease if it is administered more frequently.
  • Use latanoprost as your doctor has indicated until they tell you to stop.

Contact lens users

If you use contact lenses, you must remove them before using latanoprost. After applying latanoprost, wait 15 minutes before putting your contact lenses back in.

Instructions for use

Each carton contains 3 or 9 sachets. Open only one sachet at a time. Use all the single-dose containers before opening the next sachet.

Separate the single-dose container from the strip before use.

  1. Wash your hands and sit or stand comfortably.
  2. Gently separate the lower eyelid of the affected eye with your finger.
  3. Place the tip of the single-dose container near the eye, without touching it.
  4. Hand holding a syringe injecting medication into the skin with a beveled needle and arrow indicating the injection siteGently press the single-dose container so that only one drop falls into the eye, then release your finger from the lower eyelid.
  5. Press the tip of the affected eye, near the nose, with your finger. Apply pressure for 1 minute, keeping your eye closed.

Finger gently pulling down the lower eyelid to expose the ocular conjunctiva

  1. Repeat in the other eye, if your doctor has indicated it.
  2. After use, discard the single-dose container. Do not save it for later use.

If you use Latanoprost Yonsung with other eye drops

Wait at least 5 minutes between applying latanoprost and administering other eye drops.

If you use more Latanoprost Yonsung than you should

If you have applied more drops in the eye than you should, you may feel mild irritation in the eye, and your eyes may become red and tearful. This situation should resolve on its own, but if you are concerned, contact your doctor.

In case of overdose or accidental ingestion, consult your doctor, pharmacist, or call the Toxicology Information Service immediately, phone 91 562 04 20, indicating the medication and the amount used.

If you forget to use Latanoprost Yonsung

Continue with the next scheduled dose as usual. Do not apply an extra drop in the eye to make up for the missed dose. If you have doubts, consult your doctor or pharmacist.

If you stop using Latanoprost Yonsung

If you want to stop using latanoprost, you must consult your doctor.

If you have any other questions about using this medication, ask your doctor, pharmacist, or nurse.

Medicine questions

Started taking the medicine and have questions?

Discuss your symptoms and treatment with a doctor online.

4. Possible side effects

Like all medications, this medication can cause side effects, although not everyone will experience them.

The following adverse reactions are known with the use of latanoprost:

Very common side effects(may affect more than 1 in 10 patients):

  • Gradual change in eye color due to an increase in the amount of brown pigment in the colored part of the eye, known as the iris.
    • If you have mixed-color eyes (blue-brown, gray-brown, yellow-brown, or green-brown), you are more likely to experience this change than if your eyes are a single color (blue, gray, green, or brown).
    • The change in eye color may take years to develop, although it can usually be noticed after 8 months of treatment.
    • The change in eye color may be permanent and may be more noticeable if this medication is used in only one eye.
    • The change in eye color does not seem to be associated with the development of any problems.
    • The change in eye color does not progress once treatment with this medication has been stopped.
  • Redness of the eye.
  • Ocular irritation (feeling of stinging, feeling of grit in the eye, itching, pain, and feeling of a foreign body in the eye). If you experience severe ocular irritation that makes your eyes water excessively or makes you consider stopping treatment, consult your doctor, pharmacist, or nurse as soon as possible (within a week). You may need to have your treatment reviewed to ensure you are receiving the appropriate treatment for your condition.
  • Gradual change in the eyelashes of the treated eye and the fine hair around the treated eye, observed in most patients of Japanese origin. These changes include an increase in color (darkening), length, thickness, and number of eyelashes.

Common side effects(may affect up to 1 in 10 patients):

  • Irritation or erosion of the eye surface, eyelid inflammation (blepharitis), and eye pain, and sensitivity to light (photophobia), conjunctivitis.

Uncommon side effects(may affect up to 1 in 100 patients):

  • Swelling of the eyelids, dry eye, inflammation or irritation of the eye surface (keratitis), blurred vision, inflammation of the colored part of the eye (uveitis), swelling of the retina (macular edema).
  • Skin rash.
  • Chest pain (angina), feeling the heartbeat (palpitations).
  • Asthma, difficulty breathing (dyspnea).
  • Chest pain.
  • Headache, dizziness.
  • Muscle pain, joint pain.

Rare side effects(may affect up to 1 in 1,000 patients):

  • Inflammation of the iris (iritis), symptoms of swelling or injury/damage to the eye surface, swelling around the eye (periorbital edema), misdirected eyelashes or extra row of eyelashes, scarring of the eye surface, accumulation of fluid in the colored part of the eye (iris cyst).
  • Skin reactions on the eyelids, darkening of the eyelid skin.
  • Worsening of asthma.
  • Severe itching of the skin.
  • Development of a viral eye infection caused by the herpes simplex virus (HSV).

Very rare side effects(may affect up to 1 in 10,000 patients):

  • Worsening of angina in patients who also have heart problems.

Very rare cases of corneal calcification associated with the use of eye drops containing phosphates have been reported in some patients with significantly damaged corneas.

Reporting side effects

If you experience any side effects, consult your doctor, pharmacist, or nurse, even if they are not listed in this package leaflet. You can also report them directly through the Spanish Medication Toxicology Surveillance System: https//:notificaram.es. By reporting side effects, you can contribute to providing more information on the safety of this medication.

5. Storage of Latanoprost Yonsung

Keep this medication out of the sight and reach of children.

Do not use this medication after the expiration date shown on the packaging, carton, and single-dose container. The expiration date is the last day of the month indicated.

This medication does not require special storage conditions.

Keep the sachet in the carton once opened to protect it from light.

After opening the sachet: use the single-dose containers within 20 days.

After opening the single-dose container: use immediately and discard the single-dose container after use.

Medications should not be disposed of through wastewater or household waste. Deposit the containers and medications you no longer need at the SIGRE collection point in your pharmacy. If you have doubts, ask your pharmacist how to dispose of the containers and medications you no longer need. This will help protect the environment.

6. Contents of the pack and further information

Composition of Latanoprost Yonsung

  • The active ingredient is latanoprost 50 micrograms/ml.
  • The other ingredients (excipients) are sodium carmellose, D-mannitol, tiloxapol, sodium dihydrogen phosphate dihydrate, disodium phosphate dodecahydrate, hydrochloric acid (for pH adjustment), water for injectable preparations.

Appearance of the product and pack contents

Latanoprost Yonsung eye drops are a colorless or slightly yellowish solution in single-dose containers.

The single-dose containers are packaged in a sachet with 10 units (two strips of 5 single-dose containers), each single-dose container contains 0.2 ml of eye drops in solution.

The cartons contain 30 single-dose containers (3 sachets with 10 single-dose containers).

The cartons contain 90 single-dose containers (9 sachets with 10 single-dose containers).

Not all pack sizes may be marketed.

Marketing authorization holder and manufacturer

YONSUNG GmbH

Zeppelinstrasse 14

78244 Gottmadingen

Germany

Local representative

XENTENEL PHARMA EUROPE, S.L.

Vallsolana Garden Business Park

Camí de Can Camps, 17-19 – Kibo Building

08174 Sant Cugat del Vallès

Spain

93 836 4600

[email protected]

Date of the last revision of this package leaflet: May 2024

Detailed information about this medication is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) (http://www.aemps.gob.es/)

Online doctors for LATANOPROST YONSUNG 50 micrograms/ml eye drops in single dose containers

Discuss questions about LATANOPROST YONSUNG 50 micrograms/ml eye drops in single dose containers, including use, safety considerations and prescription review, subject to medical assessment and local regulations.

5.0 (69)
Doctor

Tarek Agami

General medicine 11 years exp.

Dr. Tarek Agami is a general practitioner registered in both Portugal and Israel, with broad experience in family and preventive medicine. He offers online consultations for adults and children, providing personalised support for primary care needs, chronic disease management, and everyday health concerns.

Dr. Agami received clinical training and worked in leading medical institutions in Israel (Kaplan Medical Center, Barzilai Medical Center, Wolfson Medical Center) and Portugal (European Healthcare City, Viscura Internacional, Hospital Dr. José Maria Grande, Hospital Vila Franca de Xira). His approach combines international medical standards with individualised attention to each patient.

Main areas of consultation:

  • Diagnosis and treatment of acute and chronic conditions (high blood pressure, diabetes, respiratory infections, cardiovascular symptoms)
  • Evaluation of symptoms and guidance on further diagnostic testing
  • Preventive check-ups and regular health monitoring
  • Medical support during travel or after relocation
  • Treatment adjustments and lifestyle recommendations based on your personal history
Dr. Agami provides medical support for patients using GLP-1 medications (such as Ozempic or Mounjaro) as part of a weight loss strategy. He offers individualised treatment planning, regular follow-up, dose adjustment, and advice on combining medication with sustainable lifestyle changes. Consultations follow the medical standards accepted in Portugal and Israel.

Dr. Agami is committed to evidence-based, patient-centred care, ensuring that each person receives trusted medical support tailored to their health goals.

Camera Book a video appointment
€69
5.0 (63)
Doctor

Nuno Tavares Lopes

Family medicine 18 years exp.

Dr. Nuno Tavares Lopes is a licensed physician in Portugal with 17 years of experience in emergency medicine, family and general practice, and public health. He is the Director of Medical and Public Health Services at an international healthcare network and serves as an external consultant for the WHO and ECDC.

  • Emergency care: infections, fever, chest/abdominal pain, minor injuries, paediatric emergencies
  • Family medicine: hypertension, diabetes, cholesterol, chronic disease management
  • Travel medicine: pre-travel advice, vaccinations, fit-to-fly certificates, travel-related illnesses
  • Sexual and reproductive health: PrEP, STD prevention, counselling, treatment
  • Weight management and wellness: personalised weight loss programmes, lifestyle guidance
  • Skin and ENT issues: acne, eczema, allergies, rashes, sore throat, sinusitis
  • Pain management: acute and chronic pain, post-surgical care
  • Public health: prevention, health screenings, long-term monitoring
  • Sick leave (Baixa médica) connected to Segurança Social in Portugal
  • IMT medical certificates for driving licence exchange
Dr. Nuno Tavares Lopes provides medical support for patients using GLP-1 medications (Mounjaro, Wegovy, Ozempic, Rybelsus) as part of a weight loss strategy. He offers individualised treatment planning, regular follow-up, dose adjustment, and advice on combining medication with sustainable lifestyle changes. Consultations follow the medical standards accepted in Europe.

Dr. Lopes also provides interpretation of medical tests, follow-up care for complex patients, and multilingual support. Whether for urgent concerns or long-term care, he helps patients act with clarity and confidence.

Camera Book a video appointment
€59
5.0 (3)
Doctor

Tomasz Grzelewski

Dermatology 21 years exp.

Dr Tomasz Grzelewski is an MD, PhD specialist in allergy, paediatrics, general practice and sports medicine, with a clinical focus on dermatology, endocrinology, allergology and sports-related health. He has more than 20 years of clinical experience and completed his medical training at the Medical University of Łódź, where he defended his PhD thesis with distinction. His doctoral research was recognised by the Polish Society of Allergology for its innovative contribution to the field. Throughout his career, he has gained extensive expertise in diagnosing and managing a wide range of allergic and paediatric conditions, including modern allergen desensitisation techniques.

For five years, Dr Grzelewski served as the Head of two paediatric departments in Poland, managing complex clinical cases and leading multidisciplinary teams. He also worked in medical centres in the United Kingdom, gaining experience across both primary care and specialist environments. With over a decade of telemedicine experience, he has provided online consultations across Europe and is valued for his clear, structured and evidence-based medical guidance.

Dr Grzelewski is actively involved in clinical programmes focused on modern anti-allergic therapies. As a Principal Investigator, he leads research projects on sublingual and oral allergen desensitisation, supporting evidence-based progress in allergy treatment for both children and adults.

In addition to his background in allergology and paediatrics, he completed dermatology studies through the Cambridge Education Group (Royal College of Physicians of Ireland) and a Clinical Endocrinology course at Harvard Medical School. This advanced training enhances his ability to manage skin manifestations of allergies, atopic conditions, urticaria, endocrine-related symptoms and complex immunological reactions.

Patients commonly seek his care for:

  • seasonal and perennial allergies
  • allergic rhinitis and chronic nasal symptoms
  • asthma and breathing difficulties
  • food and medication allergies
  • urticaria, atopic dermatitis and skin reactions
  • recurrent infections in children
  • sports-related health questions
  • general family medicine concerns
Dr Tomasz Grzelewski is known for his clear communication style, structured medical approach and ability to explain treatment options in a concise and accessible way. His multidisciplinary background across allergy, paediatrics, dermatology and endocrinology allows him to provide safe, up-to-date and comprehensive care for patients of all ages.
Camera Book a video appointment
€80

Frequently Asked Questions

Is a prescription required for LATANOPROST YONSUNG 50 micrograms/ml eye drops in single dose containers?
LATANOPROST YONSUNG 50 micrograms/ml eye drops in single dose containers requires a prescription in Spain. You can check with a doctor online whether this medicine may be appropriate for your situation.
What is the active substance in LATANOPROST YONSUNG 50 micrograms/ml eye drops in single dose containers?
The active ingredient in LATANOPROST YONSUNG 50 micrograms/ml eye drops in single dose containers is latanoprost. This information helps identify medicines with the same composition but different brand names.
Who manufactures LATANOPROST YONSUNG 50 micrograms/ml eye drops in single dose containers?
LATANOPROST YONSUNG 50 micrograms/ml eye drops in single dose containers is manufactured by Yonsung Gmbh. Pharmacy brands and packaging may differ depending on the distributor.
Which doctors can assess the use of LATANOPROST YONSUNG 50 micrograms/ml eye drops in single dose containers online?
Doctors such as Family doctors, Psychiatrists, Dermatologists, Cardiologists, Endocrinologists, Gastroenterologists, Pulmonologists, Nephrologists, Rheumatologists, Hematologists, Infectious disease physicians, Allergists, Geriatricians, Paediatricians, Oncologists may assess whether LATANOPROST YONSUNG 50 micrograms/ml eye drops in single dose containers is appropriate, depending on your situation and local regulations. You can book an online consultation to discuss your symptoms and possible next steps.
What are the alternatives to LATANOPROST YONSUNG 50 micrograms/ml eye drops in single dose containers?
Other medicines with the same active substance (latanoprost) include CATIOLANZE 50 micrograms/ml EMULSION EYE DROPS, LATANEST 50 micrograms/ml eye drops solution, LATANOPROST AUROVITAS 50 micrograms/ml EYE DROPS SOLUTION. These may have different brand names or formulations but contain the same therapeutic ingredient. Always consult a doctor before switching or starting a new medicine.
bg-pattern-dark

Stay informed about Oladoctor

News about new services, product updates and useful information for patients.

Follow us on social media